The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial

2015/02/05 by Satoru Muto, Haruna Kawano, Eiji Higashihara +6 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Cerebrospinal fluid and hydrocephalus #Fetal and Pediatric Neurological Disorders #Genetic and Kidney Cyst Diseases

paper · doi:10.1007/s10157-015-1086-2

openalex publication_date 2015/02/05 · crossref created 2015/02/05 · crossref issued 2015/02/07 · crossref published 2015/02/07 · crossref published-online 2015/02/07 · crossref published-print 2015/10/01 · crossref deposited 2019/05/29 · openalex created_date 2025/10/10 · crossref indexed 2026/06/01 · openalex updated_date 2026/07/23

Citations

• Autosomal dominant polycystic kidney disease: the last 3 years
• Prevalence and Renal Prognosis of Diagnosed Autosomal Dominant Polycystic Kidney Disease in Japan

Cited by

• Autosomal dominant polycystic kidney disease [wikipedia]